mercredi 16 mars 2016

Onco Actu du 16 mars 2016

3.1 Tabac

Quitting smoking overnight 'better than cutting down gradually' [NHS Choices]

Mother-to-be smoking concerns raised [BBC News]

4.12 Biopsies liquides

Blood analysis could offer a real-time ‘snapshot’ of melanoma treatment [Cancer Research UK]

4.13 Dép., diag. & prono. - Peau

Myriad Presents Second Pivotal Validation Study for Its myPath® Melanoma Test [Myriad]

5. Traitements

New way of targeting cancer’s most commonly mutated gene [The Institute of Cancer Research]

Why some tumors withstand treatment [MIT News]

'Astounding' study claims major breakthrough in cure for terminal breast cancer [The Telegraph]

5.10 Traitements - Essais

What next for the breast cancer research that hit the front pages? [The Institute of Cancer Research]

Why Is Still Struggling? [The Scholarly Kitchen]

5.12.2 Immunothérapies - CAR-T

NEJM corrects 3 papers after prominent cancer scientist left off credit for breakthrough [Retraction Watch]

5.2 Pharma

Roche's new PD-L1 bladder cancer drug could be on the market by September [FierceBiotech]

5.2.1 Pharma - Partenariats

Blueprint, Roche Ink Milestone Deal for Cancer Immunotherapy [Xconomy]

Roche, Blueprint sign $1bn cancer immunotherapy deal [PharmaTimes]

Sanofi signs deal worth up to $2.3 billion with DiCE Molecules [Reuters]

5.3 Traitements - FDA, EMA,...

Gilead Halts Six Cancer Trials as EMA, FDA Warn of Increased Adverse Events [RAPS]

Draft guideline on evaluation of anticancer medicinal products in man [EMA]

5.4 Traitements - Economie

The Economics Of Paying For Value [Health Affairs]

5.5 ASCO

U.S. Cancer Care System Ill-equipped to Deliver New Advances to Patients, ASCO Report Finds [ASCO]

6.10 Politiques

Scotland’s Cancer Strategy: an ambitious plan that’s good news for patients [Cancer Research UK]

6.9 Controverses

Woman Says Cancer Test Company Fired Her For Having Cancer [Forbes]